Liberty Mutual Group Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-8,894
Closed -$1.24M 870
2018
Q3
$1.24M Hold
8,894
0.03% 288
2018
Q2
$1.1M Sell
8,894
-1
-0% -$124 0.03% 333
2018
Q1
$991K Hold
8,895
0.03% 385
2017
Q4
$1.06M Sell
8,895
-198
-2% -$23.7K 0.03% 421
2017
Q3
$1.28M Sell
9,093
-5,034
-36% -$706K 0.07% 333
2017
Q2
$1.72M Buy
14,127
+1,762
+14% +$214K 0.07% 372
2017
Q1
$1.5M Sell
12,365
-3,967
-24% -$481K 0.06% 475
2016
Q4
$2M Buy
16,332
+839
+5% +$103K 0.07% 354
2016
Q3
$1.9M Sell
15,493
-529
-3% -$64.8K 0.07% 355
2016
Q2
$1.87M Buy
16,022
+1,156
+8% +$135K 0.07% 335
2016
Q1
$2.07M Buy
14,866
+1,344
+10% +$187K 0.09% 258
2015
Q4
$2.58M Buy
13,522
+409
+3% +$78K 0.1% 262
2015
Q3
$2.05M Sell
13,113
-46
-0.3% -$7.19K 0.08% 313
2015
Q2
$2.38M Sell
13,159
-3,933
-23% -$711K 0.08% 293
2015
Q1
$2.96M Buy
17,092
+835
+5% +$145K 0.09% 244
2014
Q4
$3.01M Buy
16,257
+178
+1% +$32.9K 0.09% 237
2014
Q3
$2.67M Sell
16,079
-387
-2% -$64.2K 0.09% 272
2014
Q2
$2.57M Sell
16,466
-1,661
-9% -$260K 0.08% 294
2014
Q1
$2.76M Buy
18,127
+2,248
+14% +$342K 0.09% 230
2013
Q4
$2.11M Buy
15,879
+4,071
+34% +$541K 0.07% 301
2013
Q3
$1.37M Buy
11,808
+2,511
+27% +$292K 0.05% 449
2013
Q2
$857K Buy
+9,297
New +$857K 0.03% 632